Peripheral Neuropathy
Definition
Nerve damage caused by chronic high blood glucose that affects approximately 50% of people with diabetes over their lifetime, most commonly starting in the feet and hands with symptoms of numbness, tingling, burning pain, and loss of sensation. Peripheral neuropathy results from glucose-mediated damage to small blood vessels that supply nerves, and it progresses silently — often detected only after significant nerve loss. CGM-guided glucose management that maintains time in range above 70% has been shown to slow neuropathy progression by reducing the glycemic variability that accelerates nerve damage.
Why “Peripheral Neuropathy” Matters for Glucose Monitoring
Understanding peripheral neuropathy is essential for anyone using or evaluating a continuous glucose monitor. This concept directly affects how CGM devices are designed, how glucose data is interpreted, and how clinical decisions about blood sugar management are made. Medical terms related to glucose physiology help patients and clinicians communicate effectively about blood sugar patterns, treatment goals, and the clinical significance of CGM data.
This term applies broadly across all continuous glucose monitors and is foundational knowledge for interpreting CGM data, whether you are managing diabetes or using a sensor for metabolic wellness.
Related Terms
Abnormally high blood glucose, generally defined as levels above 180 mg/dL after meals or above 130 mg/dL fasting.
The percentage of time a person's glucose level remains within a defined target range, typically 70 to 180 mg/dL for most people with diabetes.
The magnitude and frequency of blood glucose fluctuations over a defined period.
Hemoglobin A1C is a blood test that measures the percentage of hemoglobin proteins coated with sugar, reflecting average blood glucose levels over the previous 2 to 3 months.